Announcements Trials
Browse Landscape

Phase

Phase 2 225Phase 3 97Phase 1 71Phase 1/2 35Phase NA 9Phase 4 5Phase 2/3 3Phase EARLY_PHASE1 2

Status

Recruiting 5Completed 5Terminated 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Completed × Trastuzumab × Clear all
NCT02419742 2022-10-12

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

Hoffmann-La Roche

Phase 4 Completed
110 enrolled 10 charts
Breast

Breast Neoplasms

NCT02445586 2019-10-29

Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer

Hoffmann-La Roche

Phase 4 Completed
52 enrolled 41 charts
Breast

Breast Neoplasms

NCT01501487 2018-06-28

MINT

Agendia

Phase 4 Completed
226 enrolled
Breast

Breast Neoplasms

NCT01301729 2016-12-29

A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment

Hoffmann-La Roche

Phase 4 Completed
32 enrolled 11 charts
Breast

Breast Neoplasms

NCT00127933 2011-08-10

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Hoffmann-La Roche

Phase 4 Completed
157 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡